Upgrading IWD to a hold rating, due to emerging relative strength in value and cyclical sectors, despite stretched valuation. Potential outperformance hinges on value stocks' earnings growth converging with the Magnificent Seven and the US avoiding recession. IWD trades at a P/E above its historical average, with financials as the largest sector, and mixed technical/seasonal signals near $190 resistance.

I am bullish on Las Vegas Sands due to its strong presence in high-growth markets like Macao and Singapore, supporting a buy recommendation. LVS demonstrates financial resilience, robust cash flow, and liquidity, enabling continued development and shareholder returns through dividends and buybacks. The company is undervalued relative to its peers, with a forward P/E of 17.12x and strong fundamentals, offering significant upside potential to my $68.50 price target.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=149700&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.

RESTON, Va. , May 22, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) and Saudi Arabia's National Security Services Company (SAFE) will collaborate on security screening technology for airports and other ports of entry across the Kingdom under an agreement signed May 13.

GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) (“QXO” or the “Company”) announced today the pricing of its previously announced separate underwritten public offerings of (i) 48,484,849 shares of its common stock (“Common Stock”) at a public offering price of $16.50 per share (the “Common Stock Offering”), and (ii) $500 million of depositary shares (“Depositary Shares”), each representing a 1/20th interest in a share of newly issued 5.50% Series B Mandatory Convertible Preferred Stock.

Capricor's lead asset, deramiocel, targets DMD-related cardiomyopathy and faces key FDA milestones (ADCOM, PDUFA) in 2025. A strong cash position and partnership with Nippon Shinyaku provide financial stability but limit direct revenue potential from U.S. and Japan sales. Clinical data shows deramiocel slows disease progression by 52%, but regulatory approval and market adoption remain uncertain.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149698&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=149699&wire=1&utm_campaign=2 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149697&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Healthcare stock valuations are struggling to rise due to political risk and scandals, but this could create attractive entry points for long-term investors. And the reason lies in the bearish narrative surrounding two of the sector's leaders: UNH and LLY. Among healthcare ETFs, VHT stands out in my view as the most representative of the sector, in terms of performance, risk, and costs.

Diageo's stock is significantly down from its 2021 highs, but its premium brands and strong margins remain intact, despite stagnant growth and high debt. The current valuation is historically attractive, trading at a discount at only 17.7x earnings and 3x sales, making it appealing for long-term investors. Concerns about Gen Z drinking less are overstated; premium brands like Guinness and Don Julio continue to drive organic growth and long-term value.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=149695&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=149696&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

SiXG301 and SiXG302, Silicon Labs' first wireless SoC families at the 22 nm process node, deliver breakthroughs in compute, power efficiency, integration and security AUSTIN, Texas , May 22, 2025 /PRNewswire/ -- Silicon Labs, the leading innovator in low-power wireless solutions, today announced the first products of its Series 3 portfolio with the introduction of two new wireless SoC families built at the advanced 22 nanometer (nm) process node: the SiXG301 and SiXG302. These highly integrated solutions represent a significant leap forward in compute power, integration, security, and energy efficiency, addressing the growing demands of both line-powered and battery-powered IoT …

Open-Sources Neuro® AI Multi-Agent Accelerator TEANECK, N.J. , May 22, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced that it has open-sourced its Neuro® AI Multi-Agent Accelerator for research and academic use.

Introduces new PerfecTwin ERP Edition with AI capabilities such as real transaction data generation for testing and automated removal of sensitive information Expands collaboration plans with SAP to provide technical enhanced services for cloud ERP advancement Plans to establish ERP delivery center in India to expand global ERP operations CEO Shin Gyoon Hyun joins SAP Sapphire panel session for the second consecutive year to discuss ERP innovation SEOUL, South Korea , May 22, 2025 /PRNewswire/ -- LG CNS, a leading AI transformation (AX) company in Korea, unveiled its latest AI-based ERP testing technology at SAP Sapphire 2025, SAP's annual global …

VTC offers broad, investment-grade corporate bond exposure with a low expense ratio, but is overweight BBB credits and has a 6.7-year duration. Current credit spreads and rates are not attractive for entry; spreads are near historic lows and rates may move structurally higher due to inflation and deficits. We expect VTC to become attractive only after a significant widening in credit spreads, ideally above 150-200 bps, or during a recession scenario.

Dynavax Technologies' stock has dropped 25% since my last 'Hold' rating in February 2025. The company's HEPLISAV-B continues to grow at significant rates. DVAX has ample liquidity supporting a balanced capital allocation program.

Chinese electric-vehicle maker Xpeng saw its shares in Hong Kong surge over 10% Thursday. Analysts widely expect the company will likely turn profitable in the fourth quarter this year.

Brookfield Infrastructure Partners offers a compelling inflation hedge. Its diversified global assets and inflation-linked contracts support stable, rising cash flows and dividends. BIP's risk profile is low, with minimal cyclical exposure and an attractive fixed-rate, long-term debt structure that benefits from sustained inflationary environments. Despite recent stock price stagnation, the company trades at a fair valuation, with a strong 5% yield and significant upside if global inflation remains elevated.